DTB: Vol 20, No 4. July - September 2012
Medicalization of aging and the testosterone deficiency syndrome
Testosterone therapy in the management of TDS is not justified because there is no clear benefit in the relevant primary endpoints and there are alarming results on the possible risks. Increasing consumption responds to the success of awareness raising campaigns. TDS is a clear example of disease mongering.
Authors:
- Juan Gérvas. Family Physician. CESCA group, Madrid, Spain
- Enrique Gavilán. Family Physician, Montehermoso Primary Care Centre, Cáceres, Spain
- Javier Gorricho. Drug Prescribing Service. Navarre Health Service, Spain
